KILITCH — Kilitch Drugs (India) Share News
0.000.00%
- IN₹7.07bn
- IN₹7.24bn
- IN₹2.35bn
Brief: Kilitch Drugs To Divest Entire Stake In Kilitch Estro Biotech PLC
Brief: Kilitch Drugs (India) To Issue Bonus Shares In Ratio Of 1:1
Brief: Kilitch Drugs (India) Approves Issue Price For Rights Issue At 357 Rupees Per Share
Brief: Kilitch Drugs (India) To Raise Up To 500 Million Rupees Via Rights Issue
Brief: Kilitch Drugs (India) Unit Won Tender For $9.1 Mln
Brief: Kilitch Drugs (India) Approves Continuation Of Mukund Mehta As MD
Commences 1 Billion Rupees New Facility Expansion Plan
Brief: Kilitch Drugs (India) Buys Land To Establish Green Field Pharma Complex
Brief: Kilitch Drugs (India) Says To Consider Issue Of Shares Warrants Convertible Into Equity Shares
Brief: Kilitch Drugs (India) Says Starts Production Of Cephalosporin Injectables At Ethiopia Plant
Brief: Kilitch Drugs (India) CFO Sujit Kumar Dash Resigns
Unit Gets Manufacturing License To Produce 'Cephalosporin' Medicines In Ethiopia
Brief: Kilitch Drugs (India) Approves Proposal For Investing In New Green Field Project In Ethiopia
Brief: Kilitch Drugs (India) Ltd Says To Set-Up Second Green Field Project In Ethiopia
Brief: Kilitch Drugs (India) March Quarter Profit Rises
Brief: Kilitch Drugs (India) Dec-Qtr Profit Rises
Brief: Kilitch Drugs (India) To Consider Appointment Of CA Sujit Kumar Dash As CFO
Brief: Kilitch Drugs (India) CFO Shailesh Mirgal Resigns
Brief: Kilitch Drugs (India) Plans To Start Manufacturing Ops In Ethopia